|

|
ClinInvent Research Pvt Ltd
Dr. Arun Bhatt, President
A-302, Everest Chambers
Next to Star TV Office
Marol Naka, Andheri - Kurla Road
Andheri (East), Mumbai 400059 India
Phone: +91-22-2851-1860
Fax: +91-22-2851-5482
E-mail:
Web: http://www.clininvent.com
|
|
Company Profile
ClinInvent Research Pvt. Ltd, a part of TCG Lifesciences, is a Contract Research Organization (CRO) set up in August 2003, headquartered in Mumbai (India). ClinInvent provides comprehensive clinical trial management, data management, and related services covering major therapeutic areas. ClinInvent is one of the few entities in India with end-to-end capabilities in clinical trials management with global network of CROs in US, Europe and Asia Pacific
ClinInvent is a full-fledged Contract Research Organization, which provides comprehensive services for complete clinical trial management. It maximizes customer value by carrying out international quality clinical research in quality hospitals in India at a competitive cost.
Vision: Credible Capable Compatible
- Credible, a quality service provider, firm on commitments.
- Capable, a global service provider offering, full pre-clinical and clinical services, covering all major therapeutic areas.
- Compatible, a flexible organization, which will complement the sponsor’s processes and systems.
Our people
Headed by veteran clinical trials specialist, Dr Arun Bhatt Ex-Medical Director Novartis, and managed by a large team of GCP trained clinical research professionals with a rich experience of organizing clinical trials for Global Pharmaceutical companies and CROs.
Clinical Trial Management Services
Clinical Data Management and Statistics
Highlights
- Pioneer in In-sourcing clinical trials model with a global pharmaceutical major.
- International and National medical research experts in diversified therapeutic area on Advisory board
- Internal network of >700 potential investigators covering diversified therapeutic area
- Preferred partnership with global CROs MDSPS, EPS, IncResearch, ABX
- Oracle-Clinical installation and trained by Infosys
- Continuous and comprehensive internal training program to cope with changes in industrial trend and regulatory needs
- SOPs meeting International standards reviewed by International Consultant
TCG Group Umbrella
The Chatterjee Group (TCG) is a New York based entity with global operations. It is managed by a core group of professionals from diverse backgrounds spanning asset management, management consultancy, investment banking, and operations management fields. The Group specializes in recognizing situations with unrealized competitive advantages and brings to bear its management resources and experience to realize substantial and rapid value growth. Recognizing investment opportunities in the emerging markets of Asia, especially in India, the Group is in the process of building an industrial base in this region. The strategic growth areas for The Chatterjee Group in India include life sciences, biotechnology, information technology, hydrocarbons and infrastructure. Some of the notable initiatives include the $1.5 billion Haldia Petrochemicals project, CA TCG Software (JV with Computer Associates), SkyTech Solutions (JV with United Airlines), Bengal Intelligent Park and Asian Gateway. Some of Chatterjee Group’s strategic investments in the biotechnology sector include Applied Biosystems, Celera Genomics, Sepracor, Lynx Therapeutics, Genomics Collaborative Inc.
ClinInvent Research Pvt Ltd
Dr. Arun Bhatt, President
A-302, Everest Chambers
Next to Star TV Office
Marol Naka, Andheri - Kurla Road
Andheri (East), Mumbai 400059 India
Phone: +91-22-2851-1860
Fax: +91-22-2851-5482
E-mail:
|
 |
 Back to
Profiles of Industry Providers
 Click here to access this Center's WWW home page.
|